Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First TMR (transmyocardial revascularisation) patient survives 10 years:

This article was originally published in Clinica

Executive Summary

The first patient treated for angina with PLC Systems' transmyocardial revascularisation (TMR) Heart Laser System has now survived 10 years with no relapse. Errol Taylor, who is now 93 years old, was the first treated with TMR in 1990 at the San Francisco Heart Institute at Daly City, California, to reduce his angina and restore the blood flow to his heart. PLC's Heart Laser system received FDA approval in 1998.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel